...
机译:Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality Analysis
Institut National de la Sante et de la Recherche Medicale (Inserm),Univ Bordeaux;
CHU Bordeaux,CHU Bordeaux;
Clin Pharmacol Dept,CHU NantesGrp Hosp Pitie Salpetriere,Sorbonne Univ;
Alirocumab; Evolocumab; Neurocognitive disorders; Pharmacovigilance database; SIGNAL-DETECTION; REDUCING LIPIDS; CHOLESTEROL; EFFICACY; SAFETY;